ClinicalTrials.Veeva

Menu

Oxycodone Versus Sufentanil in Patient-controlled Intravenous Analgesia After Laparoscopic Hysterectomy

A

Affiliated Hospital of Nantong University

Status and phase

Enrolling
Phase 4

Conditions

Laparoscopic Hysterectomy

Treatments

Procedure: patient controlled intravenous analgesia(PCIA)

Study type

Interventional

Funder types

Other

Identifiers

NCT06690307
2024-K115-01

Details and patient eligibility

About

This study is designed to evaluate the efficacy and safety of hydrocodone in patient-controlled intravenous analgesia (PCIA) during gynecological laparoscopy, thus to explore suitable PCIA scheme to optimize postoperative pain management for patients undergoing gynecological laparoscopic surgeries.

Full description

The controlled group will receive sulfentanil for PCIA, and the test group will receive hydrocodone for PCIA. NRS scores at 1, 6, 24 and 48 hours post-surgery will be recorded. The usage of rescue analgesics and adverse events will also be recorded.

Enrollment

64 estimated patients

Sex

Female

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • selective laparoscopic hysterectomy
  • general anesthesia
  • ASA classification I - III
  • aged 18 - 65 years

Exclusion criteria

  • allergy to oxycodone or any other drugs will be used in the study
  • preoperative opioids medication
  • opioids abuse
  • hepatic or renal dysfunction
  • cardiovascular or pulmonary dysfunction
  • lack of full civil capacity or refuse to participate

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

64 participants in 2 patient groups

sulfentanil group
Active Comparator group
Description:
Participants in the active comparator group will receive sulfentanil for PCIA.
Treatment:
Procedure: patient controlled intravenous analgesia(PCIA)
Procedure: patient controlled intravenous analgesia(PCIA)
oxycodone group
Experimental group
Description:
Participants in the experimental group will receive oxycodone for PCIA.
Treatment:
Procedure: patient controlled intravenous analgesia(PCIA)
Procedure: patient controlled intravenous analgesia(PCIA)

Trial contacts and locations

1

Loading...

Central trial contact

Siyuan Liu, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems